Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis

BACKGROUND: Modification of splicing by chemotherapeutic drugs has usually been evaluated on a limited number of pre-mRNAs selected for their recognized or potential importance in cell proliferation or apoptosis. However, the pathways linking splicing alterations to the efficiency of cancer therapy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Gabriel, Maude, Delforge, Yves, Deward, Adeline, Habraken, Yvette, Hennuy, Benoit, Piette, Jacques, Klinck, Roscoe, Chabot, Benoit, Colige, Alain, Lambert, Charles
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4399393/
https://ncbi.nlm.nih.gov/pubmed/25884497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1259-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars